Results 181 to 190 of about 77,281 (309)

TANC1::HTRA1 fusion in schwannomas

open access: yes
Brain Pathology, EarlyView.
Ilay Caliskan   +3 more
wiley   +1 more source

Age‐specific melanoma risk associated with nevi: a pooled analysis from the M‐SKIP project

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Objective This study investigates the association of melanoma risk with total‐body nevus count and the presence of atypical nevi in younger (< 40 years) and older (> 60 years) individuals. Methods A pooled analysis was conducted within the M‐SKIP project, based on multiple melanoma case‐control studies.
Giulia Doi   +20 more
wiley   +1 more source

Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial. [PDF]

open access: yesDiabetes Care
Pareek M   +34 more
europepmc   +1 more source

Both Hands Assessment for children and adolescents with bilateral cerebral palsy: Content and construct validity

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
This cross‐sectional study reports on the content and construct validity of the Both Hands Assessment (BoHA) for measuring bimanual performance in children and adolescents with bilateral cerebral palsy (MACS levels I–III), aged 18 months to 18 years. Abstract Aim To investigate the content and construct validity of the Both Hands Assessment (BoHA) for ...
Gøril Okkenhaug Johansen   +5 more
wiley   +1 more source

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with an increased risk of cardiovascular disease (CVD) morbidity and mortality. This study aimed to develop the first prediction models for CVD risk in a cohort of patients with MASH.
Joe Hollinghurst   +5 more
wiley   +1 more source

Cardiovascular Outcomes in a SELECT‐Like Obesity Cohort: Real‐World Insights From the Swedish AROS Database

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background In the SELECT trial, semaglutide reduced major adverse cardiovascular outcomes (MACE) in individuals with overweight or obesity and established cardiovascular disease (CVD) but without diabetes. However, real‐world cardiovascular event rates in comparable populations remain uncharacterised.
Viveca Ritsinger   +5 more
wiley   +1 more source

Fashioning the Viking Age

open access: yes, 2022
Rimstad, Charlotte, Mannering, Ulla
core  

Home - About - Disclaimer - Privacy